Skip to main content
. 2018 Jul 31;163(11):3023–3033. doi: 10.1007/s00705-018-3966-8

Fig. 3.

Fig. 3

Inhibitors of macropincytosis block STIV infection. (A) Fluorescence microscopy of EGFP-STIV-infected cells after treatment with DMSO, EIPA or IPA-3. (B) Fluorescence intensity of EGFP-STIV-infected cells after treatment with DMSO, EIPA or IPA-3. (C) Quantitative analysis of the percentage of EGFP-STIV-infected cells by flow cytometry. (D) Western blotting detection of protein synthesis of the STIV major capsid protein after treatment with EIPA or IPA-3